Patrick Mauro Investment Advisor’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.81M Buy
31,042
+4,313
+16% +$928K 3.93% 10
2026
Q1
$5.81M Buy
26,729
+1,092
+4% +$242K 2.92% 15
2025
Q4
$5.86M Sell
25,637
-926
-3% -$211K 3.06% 15
2025
Q3
$6.15M Sell
26,563
-118
-0.4% -$24K 3.23% 13
2025
Q2
$4.89M Buy
26,681
+1,763
+7% +$328K 2.77% 16
2025
Q1
$5.22M Sell
24,918
-2,480
-9% -$482K 2.85% 14
2024
Q4
$4.87M Sell
27,398
-1,766
-6% -$325K 2.78% 17
2024
Q3
$5.75M Sell
29,164
-950
-3% -$177K 3.03% 13
2024
Q2
$5.17M Sell
30,114
-1,571
-5% -$260K 3% 14
2024
Q1
$5.77M Sell
31,685
-5,895
-16% -$1.02M 3.28% 12
2023
Q4
$5.82M Sell
37,580
-1,231
-3% -$179K 3.47% 10
2023
Q3
$5.79M Sell
38,811
-4,894
-11% -$718K 3.75% 10
2023
Q2
$5.89M Sell
43,705
-393
-0.9% -$57.6K 3.63% 10
2023
Q1
$7.03M Buy
44,098
+3,030
+7% +$463K 4.38% 8
2022
Q4
$6.64M Sell
41,068
-508
-1% -$77.9K 4.3% 8
2022
Q3
$5.58M Buy
+41,576
New +$5.97M 4.02% 9

Other funds holding ABBV

Patrick Mauro Investment Advisor's ABBV Position: Q2 2026 in Review

Patrick Mauro Investment Advisor increased its AbbVie (ABBV) stake by 16% in Q2 2026, buying an estimated $928K and bringing the position to 31,042 shares worth $7.81M. The position accounts for 3.93% of the portfolio, ranked #10.

Patrick Mauro Investment Advisor first reported a position in ABBV in Q3 2022 and has held it in 16 quarters since. 4,188 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Patrick Mauro Investment Advisor held 31,042 shares of AbbVie worth $7.81M as of Q2 2026.
  • Patrick Mauro Investment Advisor bought 4,313 AbbVie shares in Q2 2026, an estimated $928K.
  • AbbVie made up 3.93% of Patrick Mauro Investment Advisor's portfolio in Q2 2026, its #10 holding.
  • Patrick Mauro Investment Advisor first reported a position in AbbVie in Q3 2022 and has held it in 16 quarters since.
  • 4,188 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Patrick Mauro Investment Advisor's 13F filing for Q2 2026, filed 10 Aug 2026.